Tridus

Nafronyl A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.

Molecular Formula: C₂₄H₃₃NO₃

InChI: InChI=1/C24H33NO3/c1-3-25(4-2)14-16-28-24(26)21(18-22-12-8-15-27-22)17-20-11-7-10-19-9-5-6-13-23(19)20/h5-7,9-11,13,21-22H,3-4,8,12,14-18H2,1-2H3

InChIKey: InChIKey=KBAFPSLPKGSANY-UHFFFAOYAT
SMILES: CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32

Names:
    BRN 1296059
    EINECS 250-572-2
    LS 84
    nafronyl
    Naftidrofurilo [INN-Spanish]
    Naftidrofurylum [INN-Latin]
    Naftidrofuryl
    Naphtidrofuryl
    Tridus
    2-diethylaminoethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate
    2-(Diethylamino)ethyl tetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionate

Registries:
    PubChem CID 4417
    PubChem ID 177384